Cystic Fibrosis: Multisystem Manifestations & Comprehensive Care
CFTR Dysfunction Affects Every Mucus-Producing Organ
Cystic fibrosis (CF) is an autosomal recessive disorder (CFTR gene, ΔF508 most common) causing defective chloride/bicarbonate transport → thick, dehydrated mucus.
Organ-System Manifestations
| System | Key Pathophysiology | Clinical Consequences |
|---|---|---|
| Lungs | Dehydrated airway surface liquid → impaired mucociliary clearance | Chronic infection (S. aureus, P. aeruginosa), bronchiectasis, hemoptysis, pneumothorax, respiratory failure |
| Pancreas (Exocrine) | Ductal plugging → enzyme deficiency | Pancreatic insufficiency (85%): steatorrhea, malnutrition, fat-soluble vitamin deficiency (A,D,E,K) |
| Liver/Biliary | Inspissated bile → cholestasis | Focal biliary cirrhosis (5–10%), gallstones, portal hypertension |
| Intestines | Thick mucus, dysmotility | Meconium ileus (newborn), DIOS (distal intestinal obstruction syndrome), intussusception, rectal prolapse, SIBO |
| Sweat Glands | Defective Cl⁻ reabsorption | High sweat chloride (>60 mmol/L = diagnostic), heat prostration, hyponatremic dehydration |
| Reproductive | Male: CBAVD (congenital bilateral absence of vas deferens) → azoospermia (98%). Female: Thick cervical mucus → subfertility. | Assisted reproduction (TESE/ICSI) for men; most women conceive naturally. |
| Sinuses | Ostial obstruction | Chronic sinusitis, nasal polyps (50%) |
| Bone | Malabsorption (Vit D, K), inflammation, steroids, hypogonadism | Osteopenia/osteoporosis, fractures, kyphosis |
| Endocrine | Pancreatic endocrine insufficiency + insulin resistance | CF-Related Diabetes (CFRD) – 20% adolescents, 50% adults. Unique pathophysiology. |
| Kidney | Nephrolithiasis (hyperoxaluria, hypocitraturia), aminoglycoside toxicity | Renal stones, CKD |
Modern Care: Multidisciplinary CF Center
- Airway clearance (vest, hypertonic saline, dornase alfa), pancreatic enzyme replacement (PERT), nutritional optimization (high calorie, high fat, vitamins), CFTR modulators (elexacaftor/tezacaftor/ivacaftor – Trikafta – for ≥90% mutations), infection control, psychosocial support, transplant evaluation.
- Median survival now >50 years (and rising).
Early diagnosis (newborn screening) and aggressive, proactive management transform outcomes.
Bones, Joints & Muscles - Related Articles
- Understanding and Managing Bone Spur Pain: Prevention & Treatment
- Muscle Fiber (Myocyte) Structure and Function: The Contractile Unit
- Clavicle (Collarbone) and Patella (Kneecap): Anatomy and Common Injuries
- Understanding and Managing Chronic Joint Pain: Relief Options
- Understanding Polyarthritis: Causes, Symptoms & Conditions
- Choosing the Right Walking Cane: A Comprehensive Guide
- Natural Approaches to Managing Osteoarthritis Pain & Inflammation
